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PLASMA CONCENTRATIONS OF METHADONE
DURING POSTOPERATIVE PATIENT-CONTROLLED
EXTRADURAL ANALGESIAf
Y. SHIR, D. EIMERL, F. MAGORA, D. DAMM, J. SCHULTE-MONTING
AND J. CHRUBASIK
SUMMARY
Plasma concentrations of methadone were
measured by gas chromatography in 16 patients
receiving extradural methadone by continuous
infusion for relief of postoperative pain. Venous
blood samples were taken after a loading dose of
extradural methadone 2 mg and during infusion
of 0.46 mg h'1 plus patient-controlled in-
crements of 0.2-1 mg. Mean (so) plasma con-
centration of methadone was 9.8 (2.1) ng m/~'
at 15min; this did not change significantly
during the first 2 h, after which it increased
gradually to 32.2 (4.6) ng ml-1 (?< 0.001) at
the end of 24 h. The mean quantity of extradural
methadone required to produce effective an-
algesia was 10.3 (1.8) mg during the first 12 h
after operation and 6 (1.0) mg for the
subsequent 12 h. The mean amount of metha-
done for effective analgesia on the second day
was 7.6 (1.1) mg. No adverse effects were
detected during the 2-3 days of methadone
therapy. Plasma concentration of methadone
increased significantly during patient-controlled
infusion of extradural methadone in the first 24 h
after operation, suggesting rapid vascular uptake.
Systemic activity of the drug contributes to the
analgesic effect of extradural methadone.
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Many investigators have examined the
pharmacokinetics and analgesic effects of
extradural injections of opioids [1-4]. Studies on
vascular absorption of opioids such as pethidine
[5] and fentanyl [6] have demonstrated that a
major portion is absorbed initially by direct
vascular absorption from the extradural space,
followed by uptake from CSF.
Until 1987 [7], there have been no studies of the
plasma concentrations of methadone produced by
extradural administration in bolus dose or con-
tinuous infusion. The extent of systemic uptake is
influenced mainly by lipid solubility [8,9].
Methadone has a much higher lipid partition
coefficient than morphine (116 vs 1.42) and
therefore has more rapid onset of action, with less
likelihood of delayed respiratory depression [10].
It has been shown that methadone has a potency
similar to that of morphine; it produces effective
analgesia following extradural administration, but
with fewer side effects [11-13]. Its lack of urinary
complications makes it particularly suitable for
postoperative analgesia [13]. However, rapid vas-
cular absorption in combination with slow plasma
clearance [14, 15] may result in systemic cumu-
lation after repeated extradural injections or
continuous extradural infusion.
The present study was designed to assess the
safety of continuous extradural infusion of metha-
done, by measurement of plasma concentrations
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TABLE I. Patient data
Patient
No.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
Age
(yr)
58
60
28
26
61
81
56
64
73
75
58
66
53
46
64
54
Sex
F
F
M
M
M
M
F
M
M
M
F
M
F
F
M
F
Surgical procedure
Hemicolectomy
Mid sternotomy
Colonic surgery
Vagotomy pyloroplasty
Abdomino-perineal resection
Choledochojejunostomy
Abdomino-perineal resection
Abdomino-perineal resection
Aorto-bifemoral bypass
Cholecystectomy
Cholecystectomy
Resection of abdominal aortic
ancurysm
Cholecystectomy
Hemicolectomy
Radical cystectomy
Hemicolectomy
of methadone during its use in postoperative
patient-controlled analgesia.
PATIENTS AND METHODS
We studied 16 patients (seven women) aged
26-75 yr, undergoing major elective abdominal or
thoracic surgery (table I). All patients gave
informed consent to the study, which was ap-
proved by the local Ethics Committee. All patients
received general anaesthesia; premedication and
anaesthetic technique were not standardized, but
included supplementation with low doses of
fentanyl 1-2 mg kg~l i.v. After induction of an-
aesthesia, a catheter was inserted 2.5 cm into the
extradural space via an upper lumbar interspace
for administration of methadone.
On completion of surgery, a loading dose of
0.1 % racemic methadone hydrochloride 2 mg in
10% glucose was injected through the extradural
catheter, which was connected to a 5-ml plastic
syringe containing methadone. The syringe was
driven by an automatic, portable, battery-
operated infusion pump (Graseby, Medical M 26,
England). The rate of infusion was set to deliver
methadone 0.46 mg h"1 for the first 24 h after
surgery, after which it was reduced to 0.35 mg h"1.
For the first 2 h, repeated doses of methadone to
a total of 6 mg were administered by the in-
vestigator if the patient reported severe pain.
Thereafter, the patients and the nursing staff were
instructed not to allow the pain to increase above
a level of 3 (see below), and to add further boluses
of 0.2-1.0 ml solution if pain relief was inad-
equate. The syringe was refilled by the nurse
according to the regimen, which permitted
additions of methadone up to 5 mg every 6 h.
Escape analgesia was provided by systemic
opioids.
The amount of methadone required for good
analgesia was calculated separately for the first
two 12-h epochs and the second day after
operation. The patients were observed in the
recovery room during the study period and
ventilation was monitored at frequent intervals;
blood-gas tensions were measured 1 h after sur-
gery and at least twice daily thereafter.
Analgesic efficacy was assessed by a subjective
five-point pain score (0 = no pain; 1,2 = mild
pain; 3 = discomforting pain; 4 = distressing
pain; 5 = unbearable pain, intervals 0.5). During
the first 3 h of administration of methadone, the
pain score was assessed every 30 min by one of the
investigators, who collected blood samples and
administered additional analgesia if necessary.
For the remainder of the observation period, the
average of frequent score assessments (every 1 h
for the first 12 h, every 4 h for the remainder of
the study period) was calculated for the first and
second days after surgery. These two scores were
used for statistical evaluation.
Central venous blood samples were collected in
heparinized tubes before and at 15, 30, 45, 60 min
and 2, 3, 4, 6, 8, 12 and 24 h after the first dose of
extradural methadone. The blood was centrifuged
and the plasma samples were frozen and
transported to Frankfurt (W. Germany) for
analysis. Plasma concentrations of methadone
were measured by gas chromatography using a
Hewlett-Packard 5730 apparatus with a nitrogen
phosphorus detector and a Spectra Physics model
SP 4270 integrator [16]. This assay is sensitive to
concentrations of less than 1 ng ml"1 in plasma
samples as small as 1 ml. The extraction pro-
cedure for methadone as modified by one of the
authors (J.S.-M.) utilizes acid-base partitioning
steps which allow a large number of samples to be
processed rapidly. The coefficient of variation was
3.5-22 % over a concentration range of methadone
1-50 ng ml"1. The technique was linear up to
200ngml-x [7].
Linear least square regression was used for
statistical analysis of plasma concentrations of
methadone. Mean analgesic requirements for
methadone and patients' pain scores were
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TABLE II. Individual mtthadone consumption and pain scores during the first 2 days after surgery
Patient
No.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
Mean (SD)
P
Methadone
1st day
18
17
15
19
16
16
19
17
15
15
13
13
17
18
17
16
16.3(1.8)
consumption (mg)
2nd day
6
9
8
8
7
5
8
8
9
7
7
7
7
8
9
7
7.6(1.1)
<0.05
Pain score
1st day
0
2
1
3
2
0
3
2
1
2
0
1
2
1
1
0
1.3(1)
2nd day
0
0
1
0
2
0
1
0
0
1
0
2
2
1
0
0
0.6 (0.8)
<0.05
Remarks
Post-op, intubation: 4 h
Papaveretum 10 mg i.ra.
Post-op, intubation: 10 h
Papaveretum 10 mg i.m.
Post-op, intubation: 5 h
Post-op, intubation: 12 h
Urinary retention
Post-op intubation: 6 h
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FIG. 1. Mean plasma concentration of methadone during the first 24 h after operation, with continuous
patient-controlled extradural infusion of methadone.
analysed by paired Student's t test. P < 0.05 was
considered significant.
RESULTS
The mean amount of methadone consumed
during the first day was 16.3 (SD 1.8) mg (range
13-19 mg) (table II). During the first 12 h, mean
consumption of methadone was 10.3 (1.8) mg,
whereas during the next 12 h of treatment a mean
of only 6 (1.0) mg provided analgesia (P < 0.05).
As the rate of injection was set at 5 mg/11 h, the
doses used indicate substantial need for sup-
plementary methadone during the first
postoperative period, with little or no supplement
during the second 12 h. Onset of analgesia was
rapid: 5-10 min after bolus injection, either self-
administered or given by the nurse. On the second
day, significantly smaller quantities of extradural
methadone were needed, with a mean value of
7.6 (1.1) mg (range 5-9 mg) (P < 0.05). During
these two days, the pain scores were 1.3 (1) and
0.6 (0.8), respectively (P < 0.05). Two patients
who reached the prescribed limits of extradural
methadone in the first hours following surgery,
had a pain score of 3, 15 min after supplemen-
tation with methadone, and received papaveretum
10 mg i.m.
In five patients, artificial ventilation was
continued for 4—12 h after surgery. Otherwise,
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FIG. 2. Individual plasma concentrations of methadone during the first 24 h after operation, with
continuous patient-controlled extradural infusion of methadone. Min. = Mean minimum plasma
concentration of methadone in the 16 patients studied, after 15 min; Max. = mean maximum plasma
concentration of methadone in the 16 patients studied, after 24 h.
there were no respiratory complications or marked
deviation from normal values in blood-gas
tensions.
Plasma concentrations of methadone
Mean plasma concentrations of methadone
during continuous infusion with on-demand sup-
plementation in the first 24 h after operation are
shown in figure 1. Fifteen minutes after the
loading dose of extradural methadone 2 mg and
subsequent continuous infusion, the plasma con-
centration of methadone was 9.8 (2.3) ng ml"1.
The value after 60 min was not significantly
different (11.9 (2.1) ng ml"1). After the first 1 h,
plasma concentration of methadone increased
gradually, to mean values of 14.9 (2.8) ng ml"1
at 2h, 21.9 (2.8) ng ml"1 at 3h and 32.2
(4.6) ng ml"1 24 h after operation. Regression
analysis showed a significant increase in plasma
concentrations of methadone with time, with peak
values at the 2 h (P < 0.05), 3 h (P < 0.05) and
24 h (P< 0.001) of extradural infusion of
methadone.
Methadone concentrations varied considerably
between individuals (fig. 2), although the general
trend towards increased concentrations was simi-
lar in all patients. On several occasions, high
values were recorded in some patients, which
corresponded with additional boluses. Although
most patients were sleepy during the first few
hours after operation, all, including those re-
ceiving artificial ventilation, were fully conscious
and co-operative. No respiratory depression,
haemodynamic instability or neurological changes
were observed in any patient. None exhibited
signs of atelectasis on the chest x-ray taken the
morning following the operation. One of the
seven patients without a urinary catheter required
temporary catherization of the bladder.
DISCUSSION
This study has shown that postoperative pain
associated with major abdominal and thoracic
surgery was controlled effectively by continuous
lumbar extradural administration of methadone.
Intermittent extradural administration of bolus
doses of methadone has been reported to produce
good analgesia after surgery [11, 13, 17] and
extracorporeal shock wave lithotripsy [18].
Extradural methadone 8—12 mg day"1 has been
reported to give good analgesia for several weeks
without toxic effects in patients with chronic pain
[19].
The prescribed dose limit of extradural infusion
of methadone plus on-demand boluses of up to
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5 mg every 6 h was based on other studies and our
own previous experience [7, 12, 13, 18, 19]. The
mean consumption of methadone in 24 h of our
patients was less than the total amount given in
bolus injections during the same period after
thoracic surgery [17], but greater than the single
doses recommended after lower abdominal sur-
gery [13].
Lipophilic opioids are taken up more readily
from the extradural space and, therefore, are less
likely to cause late respiratory depression than
lipophobic drugs. Payne and Inturrisi [10] could
not detect methadone in the cisternal CSF of
sheep up to 6 h after injection of methadone 2 mg
into the lumbar subarachnoid space. In contrast,
subarachnoid injection of the same dose of
morphine resulted in a concentration of morphine
148 ng ml"1 in the cisterna magna, after only
2-3 h. The authors concluded that methadone, as
opposed to the hydrophilic morphine, was taken
up almost completely into the cord. This concept
is supported by previous studies of extradural
methadone and the present investigation, in which
no central side effects were observed. Continuous
infusion of methadone supplemented by patient-
controlled boluses prevented onset of severe pain;
however, its high lipophilicity leads to rapid
vascular absorption. In addition, methadone pos-
sesses a long plasma terminal half-life—more than
24 h [20,21], and this may lead to cumulation
during prolonged continuous infusion. The pres-
ent study has confirmed that methadone passed
rapidly into the circulation, as demonstrated by
the plasma concentration at 15 min. The relatively
constant plasma concentration observed during
the first 1 h of continuous infusion may be a
reflection of its rapid phase of distribution—6.1
(5.7) min [20]. The significant increase in the
subsequent 3 h may have been related either to
the kinetics of extradural methadone, or to the
increments necessary to treat immediate severe
postoperative pain. The slow increase towards the
peak concentration of 32.2 ng ml"1 at 24 h reflects
the long terminal half-life. However, the mean
24 h value was below the minimal analgesic blood
concentration (57.9 ng ml"1) reported by Gourlay,
Willis and Wilson after i.v. administration [22].
Although high plasma concentrations of metha-
done were observed occasionally, none reached a
toxic value, and there was no clinical evidence of
toxicity during the 3 days of treatment.
The good quality of analgesia in the early
postoperative period, when blood concentrations
were low, is consistent with a spinal site of action
of the drug. Because of this increasing blood
concentration of methadone, observed during the
24 h of investigation, it would be advisable to
reduce the rate of infusion until further studies
are performed.
It is concluded that the amounts of methadone
infused continuously after upper abdominal and
thoracic surgery resulted in satisfactory pain
relief; no sign of toxic effects was observed during
the study, and the range of plasma concentrations
of methadone during the first 24 h remained in the
non-toxic range.
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